Orna Therapeutics
Yessica Wiryawan is a Scientist in RNA Sciences at Orna Therapeutics, focusing on the development of assays for characterizing the immunogenicity of circular RNA and improving RNA synthesis methods. Previously, Yessica served as a Research Scientist at Integrated DNA Technologies and a Research Associate at Zymergen, where significant contributions included optimizing high-throughput screening platforms and streamlining DNA build workflows. Educational background includes a Bachelor of Science in Chemical and Biomolecular Engineering from the University of California, Berkeley. Additional roles include teaching positions and research assistantships, showcasing a diverse experience in both scientific research and education.
This person is not in the org chart
Orna Therapeutics
1 followers
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way it treats disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions.